Medicine and Dentistry
Cardiogenic Shock
100%
Hemodynamic
42%
Mitral Insufficiency
37%
Extracorporeal Membrane Oxygenation
37%
Noradrenalin
29%
Apoplexy
27%
Heart Left Ventricle Failure
27%
Congestive Heart Failure
27%
Aortic Valve Stenosis
25%
Pulmonary Artery Occlusion Pressure
22%
Breast Cancer
20%
Echocardiography
19%
Conductance Catheter
18%
Trastuzumab
17%
Right Ventricle
16%
Speckle Tracking Echocardiography
16%
Heart Function
15%
Malignant Neoplasm
15%
Cardiovascular Disease
15%
Aortic Stenosis
14%
Heart Disease
13%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
13%
Microsphere
13%
Lung Artery Pressure
12%
Heart Atrium Remodeling
12%
Right Coronary Artery
12%
Arterial Embolization
12%
Cardiac Dysrhythmia
12%
Phenylephrine
12%
Adjuvant Chemotherapy
12%
Heart Hemodynamics
12%
Patient Experience
12%
Atrial Fibrillation
12%
Patient-Reported Outcome
12%
Heart Ventricle Remodeling
12%
Serositis
12%
Assisted Circulation
12%
Body Mass Index
12%
Natural Remedy
12%
Oxygen Saturation
12%
Ejection Fraction
11%
Hazard Ratio
10%
Serum Amyloid A
10%
Embolization
9%
Heart Output
9%
Heart Left Ventricle Ejection Fraction
8%
Stroke Volume
8%
New-Onset Atrial Fibrillation
7%
Left Coronary Artery
7%
Lactic Acid
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiogenic Shock
62%
Congestive Heart Failure
62%
Breast Cancer
45%
Trastuzumab
32%
Noradrenalin
31%
Porcine Model
27%
Malignant Neoplasm
27%
Cardiovascular Disease
27%
Heart Disease
26%
Phenylephrine
25%
Anthracycline
20%
Cerebrovascular Accident
20%
Chemotherapy
18%
Cardiotoxicity
16%
Comorbidity
15%
Catecholamine
15%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
13%
Heart Left Ventricle Failure
13%
Combination Therapy
13%
Heart Ventricle Remodeling
12%
Disease Predisposition
12%
Randomized Clinical Trial
12%
Heart Arrhythmia
12%
Heart Right Ventricle Failure
12%
Lactic Acid
12%
Epirubicin
12%
Mitral Valve Regurgitation
12%
Deterioration
12%
Herbal Remedy
12%
Side Effect
12%
Milrinone
10%
Epinephrine
10%
Microsphere
9%
Diseases
6%
Vasoactive Agent
5%